Between January and June 2019, Russia produced 186.8 bln RUB worth of pharmaceutical drugs (manufacturers’ dispatch prices, VAT included), which is monetary terms (rubles) 18.8% higher than that of the same period in 2018. In physical terms, the dynamics are only +1.3% in units and +1.2% in minimum dosage units (MDU). The total volume of production for the period is around 2.1 bln units or 35.2 bln MDUs.
7/16/2019 Volume and Dynamics of Import of Ready-Made Pharmaceutical Drugs to Uzbekistan (2017 – 2018)
In 2018, Uzbekistan imported nearly 50 bln RUB worth of ready-made pharmaceuticals (CIP prices), which is in monetary terms (RUB) 3.9% higher than that in 2017. Despite the relatively low dynamics in monetary terms, the dynamics in physical terms are surprisingly high, +18%, and that was not due to changes in dosage forms. If calculated in minimum dosage units (MDU), the dynamics are +22.4%.
7/5/2019 Predicted Amounts of Additional VAT for Feed Supplement Importers to Russia (2016 – 2018, Q1 2019)
In early June, the media reported possible increase in meat prices in Russia due to feed supplement (FS) importers being charged additional VAT on top of the preferential tax rate of 10%. Until April 1 2019, most FS importers were charged the usual rate of 20% (18% until January 2019), while nearly 20% of FS import enjoyed the preferential rate of 10% in 2018. In 2016, it was around 25%, but it began rapidly decreasing in Q1 2019, when the Federal Customs Service, followed by the Ministry of Finance, toughened the preferential rate requirements.
In 2018, Russia imported 774.4 mln RUB worth of pharmaceuticals, which is in monetary terms (rubles) 8.7% higher than that of 2017, and 23.1 mln rub worth of APIs, which is monetary terms nearly 44% higher than that of 2017. The dynamics for the first three months of 2019 are even more impressive, with a 3.1 times increase for ready-made pharmaceuticals and a 3 times increase for APIs. However, this is due to lower importing activity in 2017.
Between January and March 2019, Russia imported 165,000 units of pharmaceutical drugs for clinical trials (CT), worth 3.8 bln RUB (free circulation prices), which is in monetary terms (rubles) 1.8% lower and in physical terms 17% lower than that of the same period in 2018. Despite the negative dynamics, the total number of importing products has increased by 18, to 318.
6/25/2019 Database Update: Import of Pharmaceutical Drugs Made in EEU Countries to Russia (May 2019)
Between January and May 2019, Russia imported 5.4 bln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale prices, VAT included), which is in monetary terms (rubles) 22.4% higher than that of the same period in 2018. The dynamics in physical terms (units) are around +28%, with 100 mln units.
Between January and May 2019, Russia produced 157.5 bln RUB worth of pharmaceutical drugs (manufacturers’ dispatch prices, VAT included), which is in monetary terms (rubles) 19.1% higher than that of the same period in 2018. While the dynamics are positive, they are still significantly lower than those of 2018. These dynamics are due to May’s negative dynamics in monetary terms and low positive in physical terms.
For the Russian pharmaceutical retail, the first months of 2019 were highlighted by a significant growth of the market volume in monetary terms (+6.1% in rubles) against last year’s stagnation. The high dynamics are mostly due to a surge in influenza and ARVI incidence, with the epidemiological season being rather atypical both in terms and incidence rates. The pharmaceutical inflation rates, which reached 5.6% from January to March, also contributed to the dynamics. At the same time, incomes of the population for the period have fallen by an impressive 2.3%. Russians began to actively save money, which this is not just a hypothesis; the trends of “savings behavior” are confirmed by the surveys of such organizations as VTsIOM (Russian Public Opinion Research Center) and research holding Romir.
6/4/2019 Database Update: Import of Veterinary Drugs, Feed Supplements, and Veterinary APIs to Russia (March 2019)
Between January and March 2019, Russia imported 14.2 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms (rubles) 1.8% higher than that of the same period in 2018. The dynamics of the import of veterinary drugs are +10% (6.2 bln RUB), which is the highest dynamics among the three groups. The lowest import dynamics belong to feed supplements, with -4.5% (7.5 bln RUB). The dynamics of the API import in monetary terms are +8.3%, with 529 bln RUB.
Between January and March 2019, Russia imported 25.4 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms (rubles) 15.4% higher than that of the same period in 2018. The dynamics is physical terms are -1.6% (in tons), with 2.6 thousand tons.